eファーマシー - 世界市場の考察、競合情勢、市場予測（2030年）

世界のeファーマシーの市場規模は、2023年に604億米ドル、2030年までに1,888億9,000万米ドルに達し、2024年～2030年の予測期間にCAGRで21.05%の成長が見込まれます。eファーマシーの需要は、技術に精通した消費者の増加、エンドユーザーにおけるウェブベースおよびオンラインのサービスへのアクセスの急増、病院やその他の医療サービスにおける電子処方箋の導入の増加、遠隔医療サービスの採用の増加などによって後押しされています。さらに、慢性疾患の患者人口の増加、さまざまな慢性疾患に罹患しやすい老年人口の負担の増加、スマートフォンの普及、デジタル化の進行、従来の薬局に対するeファーマシーの採用に伴う利益、オンライン処方薬の容易な入手可能性に伴う有利なオファーや割引などによって促進されており、これらが2024年～2030年の予測期間におけるeファーマシー市場の全体的な成長に寄与しています。

eファーマシーの市場力学

eファーマシー市場はさまざまな要因によって製品需要が伸びており、主な要因の1つは、医療部門でデジタル技術とeコマースの採用が増加していることです。例えば、医療産業の成長と高い経営コストにより、経営コストを削減するためにeファーマシーソリューションの利用が必要となっています。慢性疾患が一般的になるにつれ、数多くの医療製品、特に医薬品に対する需要が高まっています。

さらに、世界中でインターネットとスマートフォンの普及が進んでいるため、eファーマシーサービスの需要が高まります。例えば、国際電気通信連合（ITU）（2022）のレポートによると、2022年に推定53億人（世界人口の66％）がインターネットを利用したとされています。

電子処方箋の大きな利点は、eファーマシーのウェブサイトに簡単に電子処方箋をアップロードし、何の障害もなくオンラインで薬を注文できることです。したがって、病院やその他の医療サービスにおける電子処方箋システムの導入が増加していることも、オンラインファーマシー産業を牽引しています。情報の収集、保管、検索を行うのにはコストがかかることから、電子処方箋の導入は重要なコスト問題に対処するために不可欠です。

パンデミックにより遠隔相談サービスが急激に増加したため、eファーマシーの需要が高まっています。医療店舗は重要なサービスに分類されましたが、それでもオンラインファーマシーはパンデミックによるロックダウンの最大の受益者の1つとして浮上しました。

eファーマシーに対する需要の高まりは、立ち上げ、資金調達、買収、その他の戦略的活動の増加にもつながっています。例えば、2022年1月、ベンチャーキャピタリストのMark Cubanは、100種類以上のジェネリック医薬品を低価格で販売するデジタル薬局を立ち上げ、根本的な透明化を図っています。

また、2020年8月には、eコマース企業のAmazon IndiaがベンガルールにAmazon Pharmacyを開設しました。一般用医薬品と医療用医薬品のほか、基本的な医療サービスやインドの伝統的な漢方薬も提供しています。したがって、上記の要因が2024年～2030年の予測期間におけるeファーマシー市場の成長に寄与しています。

しかし、違法オンラインファーマシーの増加や偽造医薬品のリスクなどが、eファーマシー市場の成長を抑制する可能性があります。

eファーマシー市場のセグメント分析

eファーマシー市場の薬剤タイプセグメントでは、OTC医薬品カテゴリが2023年に大きな収益シェアを獲得すると予測されています。これは、市場での入手が容易なため、エンドユーザーの間で需要が増加していることに起因しています。

OTC医薬品は通常、頭痛、風邪、アレルギーなど自己診断が容易な症状を治療するもので、食料品店、ドラッグストア、コンビニエンスストア、スーパーマーケットなどで購入できます。このように、入手が容易であることや、消費者意識の向上、さまざまな一般的な健康問題を低コストで治療できることが、このセグメント需要を促進する主な要因となっています。

当レポートでは、世界のeファーマシー市場について調査分析し、市場規模と予測、促進要因と課題、企業と製品のプロファイルなどを提供しています。

目次

第2章 eファーマシー市場のエグゼクティブサマリー

• 調査範囲
• 市場の概要
• 競合の評価

第3章 規制分析

• 米国
• 欧州
• 日本
• 中国

第4章 eファーマシー市場の主な要因の分析

• eファーマシー市場の促進要因
• eファーマシー市場の抑制要因と課題
• eファーマシー市場の機会

第5章 eファーマシー市場のポーターのファイブフォース分析

第6章 eファーマシー市場のレイアウト

• 薬剤タイプ別
  • 処方薬
  • OTC医薬品
• 地域
  • 北米のeファーマシーの市場規模（2021年～2030年）
  • 欧州のeファーマシーの市場規模（2021年～2030年）
  • アジア太平洋のeファーマシーの市場規模（2021年～2030年）
  • その他の地域のeファーマシーの市場規模（2021年～2030年）

第7章 eファーマシー市場の企業と製品のプロファイル

• OptumRx, Inc.
• Rowlands Pharmacy
• Walmart Stores, Inc
• Walgreen Co.
• Amazon.com
• CVS Health
• Cigna
• Giant Eagle, Inc.
• The Kroger Co.
• PharmEasy
• Apollo Pharmacy
• DocMorris AG
• Netmeds.com
• Well
• Chemistdirect.co.uk
• Healthxchange Pharmacy
• LloydsPharmacy
• 1Mg
• Alto Pharmacy
• MedsEngage

第8章 KOLの見解

第9章 プロジェクトのアプローチ

第10章 DelveInsightについて

第11章 免責事項とお問い合わせ

List of Tables

• Table 1: Competitive Analysis
• Table 2: ePharmacy Market in Global (2021-2030)
• Table 3: ePharmacy Market in Global by Drug Type (2021-2030)
• Table 4: ePharmacy Market in Global by Geography (2021-2030)
• Table 5: ePharmacy Market in North America (2021-2030)
• Table 6: ePharmacy Market in the US (2021-2030)
• Table 7: ePharmacy Market in Canada (2021-2030)
• Table 8: ePharmacy Market in Mexico (2021-2030)
• Table 9: ePharmacy Market in Europe (2021-2030)
• Table 10: ePharmacy Market in France (2021-2030)
• Table 11: ePharmacy Market in Germany (2021-2030)
• Table 12: ePharmacy Market in the United Kingdom (2021-2030)
• Table 13: ePharmacy Market in Italy (2021-2030)
• Table 14: ePharmacy Market in Spain (2021-2030)
• Table 15: ePharmacy Market in the Rest of Europe (2021-2030)
• Table 16: ePharmacy Market in Asia-Pacific (2021-2030)
• Table 17: ePharmacy Market in China (2021-2030)
• Table 18: ePharmacy Market in Japan (2021-2030)
• Table 19: ePharmacy Market in India (2021-2030)
• Table 20: ePharmacy Market in Australia (2021-2030)
• Table 21: ePharmacy Market in South Korea (2021-2030)
• Table 22: ePharmacy Market in Rest of Asia-Pacific (2021-2030)
• Table 23: ePharmacy Market in the Rest of the World (2021-2030)
• Table 24: ePharmacy Market in the Middle East (2021-2030)
• Table 25: ePharmacy Market in Africa (2021-2030)
• Table 26: ePharmacy Market in South America (2021-2030)

List of Figures

• Figure 1: Competitive Analysis
• Figure 2: ePharmacy Market in Global (2021-2030)
• Figure 3: ePharmacy Market in Global by Drug Type (2021-2030)
• Figure 4: ePharmacy Market in Global by Geography (2021-2030)
• Figure 5: ePharmacy Market in North America (2021-2030)
• Figure 6: ePharmacy Market in the US (2021-2030)
• Figure 7: ePharmacy Market in Canada (2021-2030)
• Figure 8: ePharmacy Market in Mexico (2021-2030)
• Figure 9: ePharmacy Market in Europe (2021-2030)
• Figure 10: ePharmacy Market in France (2021-2030)
• Figure 11: ePharmacy Market in Germany (2021-2030)
• Figure 12: ePharmacy Market in the United Kingdom (2021-2030)
• Figure 13: ePharmacy Market in Italy (2021-2030)
• Figure 14: ePharmacy Market in Spain (2021-2030)
• Figure 15: ePharmacy Market in the Rest of Europe (2021-2030)
• Figure 16: ePharmacy Market in Asia-Pacific (2021-2030)
• Figure 17: ePharmacy Market in China (2021-2030)
• Figure 18: ePharmacy Market in Japan (2021-2030)
• Figure 19: ePharmacy Market in India (2021-2030)
• Figure 20: ePharmacy Market in Australia (2021-2030)
• Figure 21: ePharmacy Market in South Korea (2021-2030)
• Figure 22: ePharmacy Market in Rest of Asia-Pacific (2021-2030)
• Figure 23: ePharmacy Market in the Rest of the World (2021-2030)
• Figure 24: ePharmacy Market in the Middle East (2021-2030)
• Figure 25: ePharmacy Market in Africa (2021-2030)
• Figure 26: ePharmacy Market in South America (2021-2030)
• Figure 27: Market Drivers
• Figure 28: Market Barriers
• Figure 29: Marker Opportunities
• Figure 30: PORTER'S Five Force Analysis

Epharmacy Market By Drug Type (Prescription Drugs And Over-The-Counter (OTC) Drugs) and geography is expected to grow at a steady CAGR forecast till 2030 owing to the booming digital health industry and the rising consumer preference for online purchase of various drugs and devices across the globe

The global ePharmacy market was valued at USD 60.40 billion in 2023, growing at a CAGR of 21.05% during the forecast period from 2024 to 2030 to reach USD 188.89 billion by 2030. The demand for ePharmacy is being boosted by the increasing number of tech-savvy consumers, surging access to web-based and online services among the end-users, rising implementation of E-prescriptions in hospitals and other healthcare services, and the increasing adoption of telemedicine services across, among others. In addition, the rising patient population suffering from chronic diseases, the rising burden of the geriatric population prone to different chronic diseases, increasing penetration of smartphones, the increasing digitization and benefits associated with the adoption of ePharmacy over traditional pharmacies, lucrative offers and discounts along with easy availability of online prescription drugs, among others are thereby contributing to the overall growth of the ePharmacy market during the forecast period from 2024-2030.

Epharmacy Market Dynamics:

The ePharmacy market is witnessing a growth in product demand owing to various factors, one of the key factors being the increasing adoption of digital technologies and e-commerce in the healthcare sector. For instance, the growing healthcare industry and high operating costs have made it necessary to use ePharmacy solutions to reduce operational costs. Demand for numerous healthcare products, especially medications, is rising as chronic illnesses become more common.

Further, the rising adoption of the internet and smartphones across the globe will increase the demand for ePharmacy services. For instance, International Telecommunication Union (ITU) 2022, report stated that an estimated 5.3 billion people, or 66 percent of the world's population, used the internet in 2022.

The significant advantage of e-prescription is that one can easily upload their e-prescription on the e-pharmacy website and order medicine online without any hurdle. Thus, the rising implementation of e-prescribing systems in hospitals and other healthcare services is also driving the online pharmacy industry. The introduction of e-prescription is essential since it addresses a significant cost issue as it takes money to handle collecting, storing, and searching for information.

The pandemic has increased the demand for ePharmacy as there was a sudden thrust observed in teleconsulting services. Although medical stores were classified as vital services, still online pharmacies emerged as one of the largest beneficiaries of the pandemic-induced lockdown, as individuals preferred to buy medicines online to avoid the risk of disease spreading.

The rising demand for ePharmacy also leads to increased strategic activities including launches, funding, acquisitions, and others. For instance, in January 2022, Mark Cuban, the venture capitalist, launched a digital pharmacy that sells more than 100 generic pharmaceuticals at a low cost, to be radically transparent.

Also, in August 2020, E-commerce firm Amazon India launched Amazon Pharmacy, in Bengaluru. It offers both OTC and prescription drugs as well as basic health services and traditional Indian herbal medicines. Therefore, the above-mentioned factors are contributing to the growth of the ePharmacy market during the forecast period from 2024-2030.

However, the increasing number of illegal online pharmacies, the risk of counterfeit drugs, and others may restrict the ePharmacy market growth.

Epharmacy Market Segment Analysis:

ePharmacy Market by Drug Type (prescription drugs and over-the-counter (OTC) drugs), and Geography (North America, Europe, Asia-Pacific, and the Rest of the World)

In the drug type segment of the ePharmacy market, the over-the-counter drugs category is expected to amass a significant revenue share in the year 2023. This can be attributed to its increased demand among the end-users owing to their easy availability in the market.

OTC drugs typically treat conditions that are easy to self-diagnose, such as headaches, colds, and allergies, and can be purchased at grocery stores, drug stores, convenience stores, and supermarkets. Thus, the easy availability, rising consumer awareness, and the ability to treat various common health issues at lower cost are some crucial factors hastening the segmental demand.

Further, the patient doesn't have to wait around while their prescription is processed, which also saves time. In comparison to patients who must go through an additional two steps to obtain the proper drug, OTC medications save the patient time overall and expedite the process of providing relief, thereby making OTC drugs a preferable option for consumers. Moreover, these drugs can be easily purchased through e-commerce platforms without the hassle of uploading a prescription and further placing the order of drugs.

Additionally, the economic benefits of OTC drug usage are attributable to savings on drug costs and costs incurred on a clinical visit. Also, Rx to OTC switch by pharmaceutical manufacturers, a growing tendency of people toward self-medication, and the inclination of customers towards online pharmacies are strongly driving the segmental growth.

Further, increasing initiatives by the government to increase the demand for OTC drugs will also propel the market of the segment. For instance, in January 2022, the Drugs Technical Advisory Board (DTAB) approved the new OTC policy under which Indian pharmacists will allow the sale of certain medicines without a prescription, as per new over the counter (OTC) policy for drugs. The medicines like antifungal infections, analgesics (pain killers), cough syrups, decongestants, laxatives, antiseptics, medicines for gum infections, and others are approved in a list of OTC drugs by DTAB.

Thus, the above-mentioned factors are likely to propel the demand for over-the-counter (OTC) drugs, thereby contributing to the growth of the ePharmacy market during the forecast period from 2024-2030.

North America is expected to dominate the overall Epharmacy Market:

Among all the regions, North America is estimated to account for the largest share of the ePharmacy market in the year 2023. This domination is due to the rising preference for OTC drugs, increasing teleconsulting services in the region, increasing internet penetration, and rise in the adoption of digital technologies in the healthcare industry, among others will propel the market of ePharmacy in North America.

The consumer-friendly online experiences and other cutting-edge services made possible by the digital age are further driving the total market expansion in North America.

Additionally, it is anticipated that the e-pharmacy market in North America, particularly the United States, will be driven by the convenience of ordering medications from the comfort of home. The market's expansion in North America is also anticipated to be fueled by the high concentration of market participants and the adoption of cutting-edge technologies by key companies to enhance the experience of customers making online drug purchases.

Further owing to the rising demand for e-pharmacy led to a rise in the number of new players in the market. For instance, in February 2022, Medicure Inc. launched its national direct-to-consumer e-commerce pharmacy platform through its subsidiary, Marley Drug Pharmacy, in the United States. With this, Americans can buy FDA-approved pharmaceuticals at bargain prices on Marley Drug's new e-commerce website, which offers home delivery to all 50 states.

Also, in January 2022, Mark Cuban started an online pharmacy offering affordable generic medications under the name Mark Cuban Cost Plus Drug Company, a brand-new online pharmacy, in the United States.

Thus, all the above-mentioned factors will lead to an increase in the North America ePharmacy market growth during the forecasting period of 2022-2027.

Epharmacy Market Key Players:

Some of the key market players operating in the ePharmacy market include OptumRx, Inc., Rowlands Pharmacy, Walmart Stores, Inc, Walgreen Co., Amazon.com, CVS Health, Cigna, Giant Eagle, Inc., The Kroger Co., PharmEasy, Apollo Pharmacy, DocMorris AG, Netmeds.com, Well, Chemistdirect.co.uk, Healthxchange Pharmacy, LloydsPharmacy, 1Mg, Alto Pharmacy, MedsEngage, and others.

Recent Developmental Activities in the Epharmacy Market:

In September 2022, Amazon stated that it was planning to sell prescription medications online in Japan.

In January 2022, Hyphens Pharma International Limited, Singapore's largest specialty pharmaceutical as well as a consumer healthcare company, launched WellAway ePharmacy in the city-state. WellAway offers customers the ease of access to pharmaceutical services while also assisting doctors with teleconsultation

In August 2020, Reliance Retail announced the acquisition of a 60.0% equity stake in Netmeds for USD 83.0 million. The acquisition is aimed at enhancing the company's ability to offer affordable & high-quality healthcare products & services to its customers.

Key Takeaways from the Epharmacy Market Report Study

Market size analysis for current ePharmacy market size (2023), and market forecast for 5 years (2024-2030)

Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years

Key companies dominating the global ePharmacy market.

Various opportunities available for the other competitor in the ePharmacy market space.

What are the top-performing segments in 2023? How these segments will perform in 2030.

Which are the top-performing regions and countries in the current ePharmacy market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for ePharmacy market growth in the coming future?

Target Audience who can be benefited from this Epharmacy Market Report Study

ePharmacy products providers

Research organizations and consulting companies

ePharmacy-related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in ePharmacy

Various End-users who want to know more about the ePharmacy market and the latest technological developments in the ePharmacy market.

Frequently Asked Questions for the Epharmacy Market:

1. What is ePharmacy?

E-Pharmacy is a pharmacy that sells medicines on the Internet and delivers them to customers. It is an online pharmacy that operates over the Internet and provides medicines to consumers through mail or shipping companies

2. What is the market for global ePharmacy?

The global ePharmacy market was valued at USD 60.40 billion in 2023, growing at a CAGR of 21.05% during the forecast period from 2024 to 2030 to reach USD 188.89 billion by 2030.

3. What are the drivers for the global ePharmacy market?

The demand for ePharmacy is primarily being heightened by the surging internet across the globe, improving digitalization of healthcare services, increasing number of tech-savvy consumers, rising consumer preference for online purchases, increasing adoption of digital technologies and e-commerce in the healthcare sector among others, thereby contribute to the overall growth of the ePharmacy market during the forecast period from 2024-2030.

4. Who are the key players operating in the global ePharmacy market?

Some of the key market players operating in the ePharmacy market include OptumRx, Inc., Rowlands Pharmacy, Walmart Stores, Inc, Walgreen Co., Amazon.com, CVS Health, Cigna, Giant Eagle, Inc., The Kroger Co., PharmEasy, Apollo Pharmacy, DocMorris AG, Netmeds.com, Well, Chemistdirect.co.uk, Healthxchange Pharmacy, LloydsPharmacy, 1Mg, Alto Pharmacy, MedsEngage, and others.

5. Which region has the highest share in the ePharmacy market?

North America is expected to dominate the overall ePharmacy market during the forecast period from 2024-2030. Factors such as the rising adoption of e-commerce, growing geriatric population, increasing online sales, developed healthcare infrastructure, positive attitude towards the adoption of new technologies, and the presence of key players in the region, among others will positively impact the North American ePharmacy market. Furthermore, high disposable income, sophisticated healthcare infrastructure, and high awareness about telemedicine and online pharmacy services also helped the market growth in this region.

Table of Contents

1.ePharmacy Market Report Introduction

2. ePharmacy Market Executive Summary

• 2.1. Scope of the Study
• 2.2. Market at Glance
• 2.3. Competitive Assessment

3. Regulatory Analysis

• 3.1. The United States
• 3.2. Europe
• 3.3. Japan
• 3.4. China

4. ePharmacy Market Key Factors Analysis

• 4.1. ePharmacy Market Drivers
  • 4.1.1. The increasing number of tech-savvy consumers
  • 4.1.2. Surging access to web-based and online services among the end-users
  • 4.1.3. Rising implementation of E-prescriptions in hospitals and other healthcare services
  • 4.1.4. Increasing adoption of telemedicine services across
• 4.2. ePharmacy Market Restraints and Challenges
  • 4.2.1. The increasing number of illegal online pharmacies
  • 4.2.2. Risk of counterfeit drugs
• 4.3. ePharmacy Market Opportunities
  • 4.3.1. Increasing penetration in rural areas in developing countries
  • 4.3.2. Collaboration of the offline and online pharmacies

5. ePharmacy Market Porter's Five Forces Analysis

• 5.1. Bargaining Power of Suppliers
• 5.2. Bargaining Power of Consumers
• 5.3. Threat of New Entrants
• 5.4. Threat of Substitutes
• 5.5. Competitive Rivalry

6. ePharmacy Market Layout

• 6.1. By Drug Type
  • 6.1.1. Prescription Drugs
  • 6.1.2. Over-the-counter (OTC) Drugs
• 6.2. By Geography
  • 6.2.1. North America ePharmacy Market Size in USD million (2021-2030)
    • 6.2.1.1. United States ePharmacy Market Size in USD million (2021-2030)
    • 6.2.1.2. Canada ePharmacy Market Size in USD million (2021-2030)
    • 6.2.1.3. Mexico ePharmacy Market Size in USD million (2021-2030)
  • 6.2.2. Europe ePharmacy Market Size in USD million (2021-2030)
    • 6.2.2.1. France ePharmacy Market Size in USD million (2021-2030)
    • 6.2.2.2. Germany ePharmacy Market Size in USD million (2021-2030)
    • 6.2.2.3. United Kingdom ePharmacy Market Size in USD million (2021-2030)
    • 6.2.2.4. Italy ePharmacy Market Size in USD million (2021-2030)
    • 6.2.2.5. Spain ePharmacy Market Size in USD million (2021-2030)
    • 6.2.2.6. Rest of Europe ePharmacy Market Size in USD million (2021-2030)
  • 6.2.3. Asia-Pacific ePharmacy Market Size in USD million (2021-2030)
    • 6.2.3.1. China ePharmacy Market Size in USD million (2021-2030)
    • 6.2.3.2. Japan ePharmacy Market Size in USD million (2021-2030)
    • 6.2.3.3. India ePharmacy Market Size in USD million (2021-2030)
    • 6.2.3.4. Australia ePharmacy Market Size in USD million (2021-2030)
    • 6.2.3.5. South Korea ePharmacy Market Size in USD million (2021-2030)
    • 6.2.3.6. Rest of the Asia-Pacific ePharmacy Market Size in USD million (2021-2030)
  • 6.2.4. Rest of the World (RoW) ePharmacy Market Size in USD million (2021-2030)
    • 6.2.4.1. Middle East ePharmacy Market Size in USD million (2021-2030)
    • 6.2.4.2. Africa ePharmacy Market Size in USD million (2021-2030)
    • 6.2.4.3. South America ePharmacy Market Size in USD million (2021-2030)

7. ePharmacy Market Company and Product Profiles

• 7.1. OptumRx, Inc.
  • 7.1.1. Company Overview
  • 7.1.2. Company Snapshot
  • 7.1.3. Financial Overview
  • 7.1.4. Product Listing
  • 7.1.5. Entropy
• 7.2. Rowlands Pharmacy
  • 7.2.1. Company Overview
  • 7.2.2. Company Snapshot
  • 7.2.3. Financial Overview
  • 7.2.4. Product Listing
  • 7.2.5. Entropy
• 7.3. Walmart Stores, Inc
  • 7.3.1. Company Overview
  • 7.3.2. Company Snapshot
  • 7.3.3. Financial Overview
  • 7.3.4. Product Listing
  • 7.3.5. Entropy
• 7.4. Walgreen Co.
  • 7.4.1. Company Overview
  • 7.4.2. Company Snapshot
  • 7.4.3. Financial Overview
  • 7.4.4. Product Listing
  • 7.4.5. Entropy
• 7.5. Amazon.com
  • 7.5.1. Company Overview
  • 7.5.2. Company Snapshot
  • 7.5.3. Financial Overview
  • 7.5.4. Product Listing
  • 7.5.5. Entropy
• 7.6. CVS Health
  • 7.6.1. Company Overview
  • 7.6.2. Company Snapshot
  • 7.6.3. Financial Overview
  • 7.6.4. Product Listing
  • 7.6.5. Entropy
• 7.7. Cigna
  • 7.7.1. Company Overview
  • 7.7.2. Company Snapshot
  • 7.7.3. Financial Overview
  • 7.7.4. Product Listing
  • 7.7.5. Entropy
• 7.8. Giant Eagle, Inc.
  • 7.8.1. Company Overview
  • 7.8.2. Company Snapshot
  • 7.8.3. Financial Overview
  • 7.8.4. Product Listing
  • 7.8.5. Entropy
• 7.9. The Kroger Co.
  • 7.9.1. Company Overview
  • 7.9.2. Company Snapshot
  • 7.9.3. Financial Overview
  • 7.9.4. Product Listing
  • 7.9.5. Entropy
• 7.10. PharmEasy
  • 7.10.1. Company Overview
  • 7.10.2. Company Snapshot
  • 7.10.3. Financial Overview
  • 7.10.4. Product Listing
  • 7.10.5. Entropy
• 7.11. Apollo Pharmacy
  • 7.11.1. Company Overview
  • 7.11.2. Company Snapshot
  • 7.11.3. Financial Overview
  • 7.11.4. Product Listing
  • 7.11.5. Entropy
• 7.12. DocMorris AG
  • 7.12.1. Company Overview
  • 7.12.2. Company Snapshot
  • 7.12.3. Financial Overview
  • 7.12.4. Product Listing
  • 7.12.5. Entropy
• 7.13. Netmeds.com
  • 7.13.1. Company Overview
  • 7.13.2. Company Snapshot
  • 7.13.3. Financial Overview
  • 7.13.4. Product Listing
  • 7.13.5. Entropy
• 7.14. Well
  • 7.14.1. Company Overview
  • 7.14.2. Company Snapshot
  • 7.14.3. Financial Overview
  • 7.14.4. Product Listing
  • 7.14.5. Entropy
• 7.15. Chemistdirect.co.uk
  • 7.15.1. Company Overview
  • 7.15.2. Company Snapshot
  • 7.15.3. Financial Overview
  • 7.15.4. Product Listing
  • 7.15.5. Entropy
• 7.16. Healthxchange Pharmacy
  • 7.16.1. Company Overview
  • 7.16.2. Company Snapshot
  • 7.16.3. Financial Overview
  • 7.16.4. Product Listing
  • 7.16.5. Entropy
• 7.17. LloydsPharmacy
  • 7.17.1. Company Overview
  • 7.17.2. Company Snapshot
  • 7.17.3. Financial Overview
  • 7.17.4. Product Listing
  • 7.17.5. Entropy
• 7.18. 1Mg
  • 7.18.1. Company Overview
  • 7.18.2. Company Snapshot
  • 7.18.3. Financial Overview
  • 7.18.4. Product Listing
  • 7.18.5. Entropy
• 7.19. Alto Pharmacy
  • 7.19.1. Company Overview
  • 7.19.2. Company Snapshot
  • 7.19.3. Financial Overview
  • 7.19.4. Product Listing
  • 7.19.5. Entropy
• 7.20. MedsEngage
  • 7.20.1. Company Overview
  • 7.20.2. Company Snapshot
  • 7.20.3. Financial Overview
  • 7.20.4. Product Listing
  • 7.20.5. Entropy

8. KOL Views

9. Project Approach

10. About DelveInsight

11. Disclaimer & Contact Us